Serina Therapeutics (SER) Accounts Payables (2017 - 2026)
Serina Therapeutics (SER) posted Accounts Payables of $1.9 million for Q4 2025, down 29.29% sequentially from $2.7 million in Q3 2025, and up 159.54% YoY from $744000.0 in Q4 2024.
Serina Therapeutics (SER) Accounts Payables (2017 - 2026) Analysis & Trends
Serina Therapeutics has reported Accounts Payables for 9 years, with the latest figure at $1.9 million in Q4 2025.
- Quarterly Accounts Payables rose 159.54% year-over-year to $1.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.9 million (up 159.54% YoY) and the FY2025 annual result came in at $1.9 million, up 159.54% from the prior year.
- Accounts Payables eased to $1.9 million in Q4 2025 per SER's latest filing, from $2.7 million in the prior quarter.
- Over five years, Accounts Payables peaked at $4.0 million in Q1 2024 and troughed at $161000.0 in Q2 2022.
- A 5-year average of $1.3 million and a median of $1.1 million in 2022 frame the typical range for Accounts Payables.
- The sharpest annual moves came in 2022 and 2023: Accounts Payables tumbled 87.63% in 2022, then jumped 496.89% in 2023.
- Over 5 years, Accounts Payables stood at $771000.0 in 2021, then soared by 34.11% to $1.0 million in 2022, then tumbled by 43.91% to $580000.0 in 2023, then gained by 28.28% to $744000.0 in 2024, then soared by 159.54% to $1.9 million in 2025.
- According to Business Quant data, Accounts Payables over the past three periods registered $1.9 million, $2.7 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.50 Bn | 131.65 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.10 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 65.59 Bn | 60.41 Bn | 1.37 Bn | 1.52 Bn |
| 4 | Moderna | 56.75 Bn | 51.62 Bn | 52.00 Mn | 167.00 Mn |
| 5 | BeOne Medicines | 42.11 Bn | 37.01 Bn | 1.53 Bn | 470.30 Mn |
| 6 | Alnylam Pharmaceuticals | 31.64 Bn | 28.33 Bn | 992.69 Mn | 108.02 Mn |
| 7 | BioNTech SE | 27.80 Bn | 9.41 Bn | 668.28 Mn | 622.65 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn | 428.93 Mn |
| 9 | Royalty Pharma | 27.29 Bn | 26.45 Bn | - | 35.57 Mn |
| 10 | Serina Therapeutics | 43.44 Mn | 20.41 Mn | - | 1.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.86 Mn |
| Dec 31, 2025 | 1.93 Mn |
| Sep 30, 2025 | 2.73 Mn |
| Jun 30, 2025 | 1.71 Mn |
| Mar 31, 2025 | 1.19 Mn |
| Dec 31, 2024 | 744,000.00 |
| Sep 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.97 Mn |
| Mar 31, 2024 | 4.01 Mn |
| Dec 31, 2023 | 580,000.00 |
| Sep 30, 2023 | 1.17 Mn |
| Jun 30, 2023 | 961,000.00 |
| Mar 31, 2023 | 1.26 Mn |
| Dec 31, 2022 | 1.03 Mn |
| Sep 30, 2022 | 792,000.00 |
| Jun 30, 2022 | 161,000.00 |
| Mar 31, 2022 | 501,000.00 |
| Dec 31, 2021 | 771,000.00 |
| Sep 30, 2021 | 924,000.00 |
| Jun 30, 2021 | 1.30 Mn |